Assessment of length, readability of informed consent documents for COVID-19 vaccine trials
What The Study Did: Length, readability and complexity of informed consent documents for the COVID-19 vaccine phase III randomized clinical trials were assessed in this quality improvement study.
Authors: Ezekiel J. Emanuel, M.D., Ph.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2021.10843)
Editor's Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author ...








